Related Experiment Video

Updated: Jun 28, 2026

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction
03:42

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction

Published on: March 29, 2024

Hyperleptinemia--non-haemodynamic risk factor for the left ventricular hypertrophy development in hypertensive

Kristina Selthofer-Relatić1, Radivoje Radić, Vedrana Vizjak

  • 1Clinic of Internal Medicine, University Hospital "Osijek", Osijek, Croatia. kristina.selthofer@os.t-com.hr

Collegium Antropologicum
|November 6, 2008
PubMed

Insights

Obesity is linked to hypertension and left ventricular hypertrophy (LVH). This study found higher leptin levels in overweight women with LVH, suggesting hyperleptinemia is a non-hemodynamic factor contributing to LVH.

Area of Science:

  • Cardiology
  • Endocrinology
  • Obesity Research

Background:

  • Obesity is strongly associated with hypertension and left ventricular hypertrophy (LVH).
  • LVH development involves both hemodynamic and non-hemodynamic factors.
  • Humoral mechanisms contributing to LVH require further elucidation.

Purpose of the Study:

  • To investigate if hyperleptinemia acts as a non-hemodynamic factor in LVH development.
  • To explore the role of hyperleptinemia alongside hemodynamic factors in overweight females.

Main Methods:

  • Study included 36 overweight, non-diabetic females (BMI 25-30 kg/m²).
  • Patients were categorized into hypertensive with LVH (n=21) and hypertensive without LVH (control, n=15).
  • Measurements included metabolic profiles, anthropometrics, 2D ultrasound for cardiovascular assessment, and serum leptin via RIA.

Main Results:

  • Serum leptin levels were significantly elevated in hypertensive, overweight females with LVH compared to controls.
  • This indicates a correlation between hyperleptinemia and the presence of LVH in this cohort.

Conclusions:

  • Hyperleptinemia may be a significant non-hemodynamic factor contributing to LVH.
  • This finding is relevant for understanding LVH development in hypertensive, overweight adult females.

More Related Videos

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study03:05

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...